Overview

Update
Status
Acquired by on August 27, 2013
Total Equity Funding
$20M in 1 Round from 2 Investors
Headquarters:
Rockville, MD
Description:
Amplimmune is a product-driven company offering immune-based biologics to treat patients with cancer, autoimmunity, and infectious diseases.
Categories:
Health Care, Biotechnology, Medical
Website:
http://www.amplimmune.com
Social:

Company Details

Update
Founded:
Unknown
Contact:
3013099800
Employees:
1k - 5k | 3 in Crunchbase

Amplimmune is a product driven company that is developing immune-based biologics to treat patients in the areas of cancer, autoimmunity, transplantation and infectious diseases. Amplimmune's scientific founders from Johns Hopkins University have identified several key immunological ligands and receptors. These immunological checkpoint and co-stimulatory molecules are the basis for developing a new class of biological treatments which modulate critical mechanisms in the body's immune system with the aim of bettering the lives of patients suffering from aberrant immunological conditions.

Funding Rounds (1) - $20M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jan, 2006$20M / Series A2

Investors (2)

Current Team (3)

Update

Board Members and Advisors (2)

Update

Offices/Locations (1)

Update
  • Office

    9800 Medical Center Drive

    Suite C-120

    Rockville, MD 20850

    USA

Past Team (3)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos